Celon Pharma SA (CLN) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.00x
Celon Pharma SA (CLN) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting zł0.00 (capex zł0.00 ) from operating cash flow of zł36.63 Million. Explore CLN capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
zł0.00
Capex + Investments
Operating Cash Flow
zł36.63 Million
PLN
Capital Expenditures
zł0.00
PLN
Celon Pharma SA Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Celon Pharma SA across 10 annual periods. Also explore CLN total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Celon Pharma SA (2012–2025)
Year-by-year capital reinvestment analysis for Celon Pharma SA. For live market cap and broader valuation context, see market value of Celon Pharma SA.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | zł0.00 | zł23.85 Million | zł0.00 | ▼ -100.0% |
| 2021 | 2.76x | zł121.22 Million | zł43.95 Million | zł41.35 Million | ▲ +35.2% |
| 2020 | 2.04x | zł144.60 Million | zł70.90 Million | zł99.16 Million | ▼ -14.6% |
| 2018 | 2.39x | zł67.47 Million | zł28.24 Million | zł67.46 Million | ▲ +92.8% |
| 2017 | 1.24x | zł31.35 Million | zł25.30 Million | zł31.34 Million | ▲ +20.2% |
| 2016 | 1.03x | zł21.29 Million | zł20.65 Million | zł21.29 Million | ▲ +20.4% |
| 2015 | 0.86x | zł44.86 Million | zł52.37 Million | zł44.86 Million | ▼ -7.5% |
| 2014 | 0.93x | zł22.55 Million | zł24.36 Million | zł22.55 Million | ▲ +38.6% |
| 2013 | 0.67x | zł5.64 Million | zł8.45 Million | zł5.64 Million | ▲ +97.8% |
| 2012 | 0.34x | zł4.34 Million | zł12.87 Million | zł4.34 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow